Three Seasons Wealth, LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 2044495 SALT LAKE CITY, UT

Position in SMMT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$187,501

-$56,495 QoQ

Shares Held

12,869

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#151

of 242 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Three Seasons Wealth, LLC holds $2,869,679 across 5 Biotechnology names. SMMT ranks #4 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	30,814	$1,676,589
2	SRRK	Scholar Rock Holding Corp	11,068	$608,740
3	RVMD	Revolution Medicines, Inc.	1,765	$330,549
4	SMMT	Summit Therapeutics Inc. This page	12,869	$187,501
5	SPRO	Spero Therapeutics, Inc.	30,000	$66,300

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$187,501	12,869	0.0%	Shares	Sole	2026-08-13
2026-03-31	$243,996	12,869	0.0%	Shares	Sole	2026-05-05
2025-12-31	$225,078	12,869	0.0%	Shares	Sole	2026-01-15
2025-09-30	$265,873	12,869	0.0%	Shares	Sole	2025-10-17
2025-06-30	$273,852	12,869	0.0%	Shares	Sole	2025-07-10
2025-03-31	$248,243	12,869	0.0%	Shares	Sole	2025-05-09
2024-12-31	$229,647	12,869	0.0%	Shares	Sole	2025-02-14
2024-09-30	$281,831	12,869	0.0%	Shares	Sole	2025-04-04
2024-06-30	$100,378	12,869	0.0%	Shares	Sole	2025-04-04
2024-03-31	$53,277	12,869	0.0%	Shares	Sole	2025-04-04
2023-12-31	$33,588	12,869	0.0%	Shares	Sole	2025-04-04
2023-09-30	$24,065	12,869	—	Shares	Sole	2025-04-04
No filing history on record for this holder in this stock.